Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem

Deep News

2025/11/14

Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.

Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.

The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1169368448"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169368448\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169368448?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169368448","market":"nz","top_or_hot":-1,"title":"Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem","media":"Deep News","content":"<p>Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.</p>\n<p>Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.</p>\n<p>The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time smaller\">2025-11-14 20:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.</p>\n<p>Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.</p>\n<p>The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"質押式回購","start_time":0,"source_url":"","article_id":"1169368448","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169368448","pubTimestamp":1763124042,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300037":"新宙邦","300497":"富祥药业","BK0077":"质押式回购","IE0005HP3H50.USD":"GUINNESS CHINA \"C\" (USD) ACC","BK0028":"国家队","BK0132":"高送转概念","BK0201":"可转债","BK0076":"特斯拉","LU0128522744.USD":"TEMPLETON EMERGING MARKETS \"A\" ACC","BK0155":"锂电池","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU0229945570.USD":"TEMPLETON BRIC \"A\" (USD) ACC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU0708995153.HKD":"TEMPLETON EMERGING MARKETS \"A\" (HKD) ACC","BK4124":"机动车零配件与设备","VC":"伟世通","LU0543330566.HKD":"TEMPLETON BRIC \"A\" (HKD) ACC","LU0029874905.USD":"TEMPLETON EMERGING MARKETS \"A\" INC","BK0239":"医药制造","BK0003":"超级电容","IE00BZ199S13.USD":"BNY MELLON MOBILITY INNOVATION \"B\" (USD) ACC","BK0229":"化学制品","LU0320764243.SGD":"FTIF - Templeton Emerging Markets A Acc SGD","002709":"天赐材料"},"translate_title":"富欣药业：VC和FEC产品的主要客户包括天赐材料和Capchem","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300037":1,"300497":1,"002709":1,"VC":1},"content_text":"Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.\nPlans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.\nThe company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}